发明名称 |
Calebin A for osteoporosis |
摘要 |
Disclosed is the therapeutic potential of Calebin A for osteoporosis (bone loss) caused by aging or chronic disease conditions like cancer. Calebin A is shown to down modulate osteoclastogenesis induced by receptor activator of nuclear factor (NF)-κB ligand (RANKL) signalling thereby having therapeutic potential for osteoporosis. |
申请公布号 |
US9539232(B1) |
申请公布日期 |
2017.01.10 |
申请号 |
US201615228142 |
申请日期 |
2016.08.04 |
申请人 |
Majeed Muhammed;Nagabhushanam Kalyanam |
发明人 |
Majeed Muhammed;Nagabhushanam Kalyanam |
分类号 |
A61K31/215;A61K31/216;A61K8/67 |
主分类号 |
A61K31/215 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of inhibiting osteoclastogenesis in mammals, said method comprising steps of bringing into contact mammalian osteoclast progenitor cells with an effective concentration of calebin A to bring about effect of inhibiting differentiation of said progenitor cells into osteoclasts. |
地址 |
Edison NJ US |